Abstract:Background Abnormal phenotypic switch of vascular smooth muscle cell (VSMC) is a hallmark of vascular disorders such as atherosclerosis and restenosis after angioplasty. Recently, microRNAs (miRNAs) emerge as critical regulators for vascular smooth muscle cell (VSMC) function. Our initial study identified miR-663 as one of the most sharply downregulated miRNAs in human proliferative aortic smooth muscle cells. Hypothesis MiR-663 is implicated in human VSMC phenotypic switch and the development of neointima formation. Methods and Results By using quantitative real-time PCR (qRT-PCR), we found that microRNA-663 (miR-663) was significantly downregulated in cultured human aortic VSMCs upon platelet-derived growth factor (PDGF) treatment, whereas its expression was markedly increased during VSMC differentiation as induced by either retinoid acid or SMC differentiation medium, a condition which induces SMC differentiation and inhibits cell proliferation. Furthermore, we demonstrated that overexpression of miR-663 significantly increased the expression of VSMC differentiation marker genes, such as SM22α, SM α-action, calponin, and SM myosin heavy chain, suggesting that miR-663 is a novel modulator implicated in human VSMC phenotypic switch. Moreover, miR-663 potently inhibited PDGF induced VSMC proliferation and migration. Mechanistically, we identified JunB as a downstream target of miR-663 in human VSMCs. Indeed, overexpression of miR-663 markedly inhibited the expression of the transcription factor JunB as well as its downstream molecules including matrix metallopeptidase-9 (MMP-9) and myosin light chain-9 (Myl9), thus inhibiting VSMC proliferation and migration. Finally, we showed that adeno-miR-663 markedly suppressed the neointimal lesion formation by approximately 50% in mice after vascular injury induced by carotid artery ligation, specifically via decreased JunB expression. Conclusion These results indicate that miR-663 is a novel modulator implicated in human VSMC phenotypic switch through targeting JunB expression and suggest that specific modulation of miR-663 in human VSMCs may represent a novel and attractive approach for the treatment of vascular proliferative diseases.

MicroRNA-541 Promotes the Proliferation of Vascular Smooth Muscle Cells by Targeting IRF7.

MiR-340 Promotes the Proliferation of Vascular Smooth Muscle Cells by Targeting von Hippel–Lindau Tumor Suppressor Gene

Mir-145-5p Inhibits Vascular Smooth Muscle Cells (vsmcs) Proliferation and Migration by Dysregulating the Transforming Growth Factor-b Signaling Cascade.

MicroRNA-638 is Highly Expressed in Human Vascular Smooth Muscle Cells and Inhibits PDGF-BB-induced Cell Proliferation and Migration Through Targeting Orphan Nuclear Receptor NOR1.

Mir-503 Inhibits Platelet-Derived Growth Factor-Induced Human Aortic Vascular Smooth Muscle Cell Proliferation and Migration Through Targeting the Insulin Receptor

MicroRNA-92 regulates vascular smooth muscle cell function by targeting KLF4 during vascular restenosis and injury

LINC00472 regulates vascular smooth muscle cell migration and proliferation via regulating miR-149-3p

miR‐200a‐3p inhibits the PDGF‐BB‐induced proliferation of VSMCs by affecting their phenotype‐associated proteins

MiR-411-5p Promotes Vascular Smooth Muscle Cell Phenotype Switch by Inhibiting Expression of Calmodulin Regulated Spectrin-Associated Protein-1

Involvement Of Microrna-21 In Vascular Smooth Muscle Cell Migration Reveals A Novel Mechanism In Cell Motility In Proliferative Vascular Disease

miR-654-5p suppresses migration and proliferation of vascular smooth muscle cells by targeting ADAMTS-7.

MicroRNA-363 Regulation in Proliferation and Migration of Human Umbilical Vascular Smooth Muscle Cells

MicroRNA-222 Promotes the Proliferation of Pulmonary Arterial Smooth Muscle Cells by Targeting P27 and TIMP3

Mirna-181A/b Regulates Phenotypes of Vessel Smooth Muscle Cells Through Serum Response Factor.

MiR-542-3p controls hepatic stellate cell activation and fibrosis via targeting BMP-7.

Flow-Regulation Of Vascular Smooth Muscle Cell Proliferation: Roles Of Endothelial Cell-Secreted Microrna-126

A Necessary Role of Mir-221 and Mir-222 in Vascular Smooth Muscle Cell Proliferation and Neointimal Hyperplasia.

MicroRNA-10b Induces Vascular Muscle Cell Proliferation Through Akt Pathway by Targeting TIP30.

Functional screening identifies novel miRNAs inhibiting Vascular Smooth Muscle Cell proliferation

Abstract 212: MicroRNA-663 is a Novel Regulator of Human Vascular Smooth Muscle Cell Phenotypic Switch in vitro and Neointimal Formation in vivo

MiR-26a contributes to the PDGF-BB-induced phenotypic switch of vascular smooth muscle cells by suppressing Smad1.